Posted by Michael Wonder on 01 Sep 2020
Canada secures deals for up to 114 million doses of potential COVID-19 vaccines from U.S. drug companies
31 August 2020 - Potential vaccine could be available by spring of next year.
Maryland-based biotechnology company Novavax announced in a press release Monday that it has struck a deal to produce 76 million doses of a vaccine it is working on for the Canadian government, should the vaccine ever get Health Canada approval.
Later in the day, Ottawa announced it has signed a separate deal with a subsidiary of New Jersey-based drug conglomerate Johnson & Johnson to secure up to 38 million doses of the company's potential vaccine, which is completely different from Novavax's.
